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Bioflavonoids attenuate renal proximal tubular cell injury dur- Waiting lists for kidney transplantation are expanding.
ing cold preservation in Euro-Collins and University of Wis- Therefore, it appears crucial to improve long-term allo-
consin solutions. graft outcome. Cold ischemia/reperfusion injury of trans-Background. Cold ischemia and reperfusion during kidney
planted kidneys is associated with acute tubular necrosistransplantation are associated with release of free oxygen radi-
leading to delayed graft function and reduced short-termcals and damage of renal tubular cells. Bioflavonoids may di-
minish cold storage-induced injury due to antioxidant and iron allograft survival. Delayed graft function may be due to
chelating activities. This study was designed to delineate the ischemic and immunologic causes that may act synergisti-
renoprotective mechanisms of bioflavonoids and to define the
cally. The initial ischemic insult may up-regulate thestructural features conferring cytoprotection from cold injury.
expression of class I and II major histocompatibility com-Methods. LLC-PK1 cells were preincubated for three hours
with bioflavonoids and cold stored in University of Wisconsin plex (MHC) molecules, thus increasing the immunoge-
(UW)- or Euro-Collins (EC)-solution for 20 hours. After re- nicity of the ischemic organ and inducing acute rejection
warming, cell viability was assessed by the lactate dehydroge- episodes [1]. Although the first-year survival rate of allo-nase (LDH) release, MTT-test, and amino acid transport activ-
grafts continues to improve, principally because of prog-ity. Lipid peroxidation was assessed from the generation of
ress in immunosuppressive therapy, and in the diagnosisthiobarbituric acid-reactive substances.
Results. Twenty-hours of cold storage of LLC-PK1 cells re- and treatment of acute graft rejection, the annual rate
sulted in a substantial loss of cell integrity that was more pro- of kidney graft loss caused by chronic transplant dysfunc-
nounced in the EC (LDH release, 93.6  1.6%) than the UW
tion has not changed over the last decade [2]. The mainsolution (67.2  6.9%; P 0.0001). Pretreatment with querce-
cause of late graft loss is chronic transplant nephropathytin significantly enhanced cell survival (LDH release, 5.4 
2.7% for UW and 8.4  4.2% for EC) in a concentration caused by alloreactive and non-alloreactive factors, and
dependent manner. Structure-activity studies revealed similar there is growing evidence that delayed graft function
renoprotection for kaempferol, luteolin and fisetin, unlike myr- also contributes to the development of chronic allografticetin, morin, apigenin, naringenin, catechin, silibinin and rutin.
rejection [3, 4]. Thus, attenuating cold ischemia/reperfu-Lipid peroxidation was reduced (UW alone, 2.7  1.2 vs. UW-
sion injury may prevent delayed graft function and con-quercetin 0.5  0.2 nmol/mg protein, P  0.01), and l-threo-
nine uptake completely sustained by pretreatment with querce- secutively improve long-term outcome of kidney trans-
tin, kaempferol, luteolin, and fisetin. However, renoprotection plantation.
by fisetin was rapidly lost during rewarming. Protective proper-
The strategy commonly used to reduce ischemic injuryties of bioflavonoids were governed by the number and ar-
during cold storage is the rapid flushing and cooling ofrangement of hydroxyl substitutes, electron-delocalization, ste-
rical planarity, and lipophilicity of the basic diphenylpyran the organs to 4C using preservation solutions specifically
skeleton. developed to minimize enzymatic activity and energy sub-
Conclusion. Cold storage-induced renal tubular cell injury strate depletion. For both cold storage- and reperfusion-is ameliorated by bioflavonoids. Renoprotective effects of bio-
induced injury, reactive oxygen species (ROS) play anflavonoids are defined by structure, suggesting that flavonoids
important pathogenetic role, mainly by provoking lipidare incorporated into membrane lipid bilayers and interfere
with membrane lipid peroxidation. peroxidation [5–7]. However, both the Euro-Collins (EC)
and University of Wisconsin (UW) preservation solutions
have limitations in preventing oxidative injury, and theKey words: transplantation, cold storage, lipid peroxidation, free radi-
cals, bioflavonoids, organ preservation, ischemia/reperfusion injury. addition of antioxidants to preservation solutions has
resulted in improved cell survival [8]. Interestingly, in a
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Bioflavonoids are a group of naturally occurring poly- storage was started after replacement of regular cell cul-
ture medium by 200 L/well of pre-cooled preservationphenolic compounds with a wide range of biological,
pharmacological and medicinal properties including anti- solution. After 20 hours of cold exposure cells were trans-
ferred to a cell incubator for rewarming at 37C in 95%inflammatory, anti-allergic, antiviral, antithrombotic, anti-
mutagenic, antineoplastic, and hepatoprotective effects air/5% CO2 for 60 minutes. These 60-minute rewarming
periods were performed without prior medium replace-[10–12]. Bioflavonoids represent essential nutrition com-
ponents with an average Western diet, providing 20 mg ment, except for studies of amino acid transport activity
and lipid peroxidation. In experiments with extendedto 1 g per day [13]. Recently, much attention has been
paid to their antioxidant activities and their potency to rewarming periods preservation solutions were replaced
immediately after cold storage by prewarmed FCS-freeinhibit lipid peroxidation, both related to their radical
scavenging capacity [14–17]. An inverse relationship be- medium 199. Bioflavonoids were added from stock solu-
tions exclusively to regular culture medium three hourstween the amount of dietary flavonoid consumption and
risk of coronary heart disease has been reported [18, 19]. prior to cold storage (pre-incubation). Flavonoid stock
solutions (100 mmol/L) were prepared in dimethylsulf-As natural compounds abundantly present in human nu-
trition, bioflavonoids are an interesting class of sub- oxide (DMSO) and stored in the dark at room tempera-
ture for up to four weeks. Vehicle alone (DMSO) hadstances with potential renoprotective activities useful for
improving organ preservation. However, before flavo- no influence on cell viability.
noids can be used in studies of renal organ procurement,
Determination of cell injuryit is necessary to identify those structural characteristics
Lactate dehydrogenase release. Release of cytoplas-conferring optimum renoprotection. This will facilitate
mic lactate dehydrogenase (LDH) as indicator of mem-the selection of potentially useful bioflavonoids from a
brane damage was measured spectrophotometrically us-variety of more than 4000 flavonoids known to date [20].
ing a commercial cytotoxicity detection kit (BoehringerTo our knowledge, the present study is the first to apply
Mannheim, Mannheim, Germany). The percentage ofstructure-activity studies of bioflavonoids to a model of
total cellular LDH released into the supernatant wasrenal cold ischemia/reperfusion injury, thus setting a base
taken as parameter of structural cell injury.for further studies of bioflavonoids in renal transplanta-
MTT-test. Cell viability was assessed using the MTTtion and organ preservation.
[3-(4,5-dimethylthiazol-2-yl)-2,5-dimethyltetrazolium
bromide] assay, which was performed according to Mos-METHODS
mann [21]. Conversion of MTT, a tetrazolium salt, into
Chemicals formazan depends on activity of nicotinamide adenine
All chemicals were purchased from Sigma Chemical dinucleotide (NADH) and NADH-dependent dehydro-
Co. (Munich, Germany) unless otherwise noted. genases, and thus the MTT-test is an indicator of cell
metabolic activity. The data are presented as the percent-
Cell culture age of undamaged control cells.
LLC-PK1 cells, a proximal tubular epithelial cell line of Assessment of lipid peroxidation. To assess cellular
pig origin, were obtained from American Type Culture lipid peroxidation, preservation solutions were replaced
Collection (ATCC; Rockville, MD, USA) and grown in immediately after cold storage by prewarmed medium
phenol red-free medium 199 (M199) containing ferric A (concentrations in mmol/L: NaCl 110.0, KCl 5.0, MgSO4
nitrate and supplemented with 10% fetal calf serum (FCS; 1.0, KHCO3 1.58, CaCl2 1.25, NaHCO3 6.42, Na2HPO4
PAA Laboratories, Coelbe, Germany) and 4 mmol/L 1.0, HEPES 20.0, glucose 5.55; pH 7.4) supplemented
l-glutamine (Greiner, Frickenhausen, Germany) at 37C with 0.05 mmol/L FeCl3 and 0.075 mmol/L ethylenedi-
under a humidified atmosphere of 95% air and 5% CO2 aminetetraacetic acid (EDTA). Ferrous medium was
without the addition of antibiotics. For experimental chosen to facilitate lipid peroxidation. After four hours
studies cells were grown to confluence in 96- or 24-well of rewarming, formation of malondialdehyde (MDA)
plates. Only confluent cell monolayers showing “dome was measured in the supernatant as thiobarbituric acid
formation” were used for experiments. reactive substance (TBARS) according to Aust [22]. Su-
pernatants (200 L/well) were removed and butylated
Experimental protocol hydroxytoluene (final concentration 0.01%) was added
Cold ischemia injury was simulated by storage of con- immediately to minimize lipid peroxidation during pro-
fluent cell monolayers in a temperature monitored refrig- cessing. Spectrophotometric analysis was performed at
erator at 4C under room atmosphere in either of two 532 nm. Amounts of TBARS generated (nmol/mL) were
commercial kidney preservation solutions, University of read from standard curves (0.16 to 10 nmol/mL) and
Wisconsin (UW; DuPont Pharma, Bad Homburg, Ger- corrected for cellular protein content (nmol/mg protein).
many) or Euro-Collins solution (EC; Fresenius AG, Bad The Bradford method was used to assess protein concen-
tration of each well [23].Homburg, Germany), as described recently [7]. Cold
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Amino acid transport activity. Our technique for study-
ing cellular amino acid transport activity has been de-
scribed recently [24]. A Krebs-Ringer phosphate (KRP)
buffer, pH 7.40, was used as uptake medium. The compo-
sition of sodium-KRP was (in mmol/L): KCl 6.0, MgSO4
1.2, KHCO3 2.0, CaCl2 0.5, NaCl 118, d-sucrose 5.5,
Na2HPO4 25.0. For studies of sodium-independent up-
take sodium chloride and sodium hydrogen phosphate
were replaced by choline chloride or choline phosphate
in equimolar concentrations (CH-KRP). In these experi-
ments 60 minutes of rewarming after cold storage was
performed in CH-KRP (500 L/well). Amino acid up-
take studies were started by removing CH-KRP and
simultaneously adding to the wells 250 L of uptake
medium containing a mixture of unlabeled and tritium
labeled l-threonine (Amersham Pharmacia Biotech, Buck-
inghamshire, UK). During the study procedure plates
were shaken continuously to avoid unstirred aqueous
layer effects. After exactly 60 seconds the uptake medium
was decanted and ice-cold CH-KRP was added twice,
for 20 seconds each. Intracellular threonine was extracted
from the cell layer with 250 L of 5% trichloroacetic
acid for one hour, and the extract was subjected to liquid
scintillation counting using scintillant fluid 3a70B (RPI).
The protein content of each cell layer was determined
according to the method of Bradford [23]. Amino acid
uptake is calculated as pmolmg protein1 min1 and Fig. 1. Cold-induced injury in LLCPK1 cells. Cells were cold stored
expressed as mean  SEM. Results for sodium-depen- at 4C in the University of Wisconsin (UW; , ) or Euro-Collins
solution (EC; , ) over a period of 0.5 to 20 hours, followed by 60dent uptake were derived by subtraction of sodium-inde-
minutes of rewarming at 37C. Cell injury was measured by lactatependent uptake rates from total uptake rates. All experi- dehydrogenase (LDH) release (A ) and 3-(4,5-dimethylthiazol-2-yl)-
ments were repeated at least four times (N  3 for total 2,5-dimethyltetrazolium bromide (MTT) assay (B ). Each time point
represents mean  SD of N 	 30. Differences between the UW andand sodium-independent uptake each).
EC solutions were significant at each time point (P  0.05).
Statistical analysis
Data are expressed as the mean  SD (except amino
acid transport, which is mean  SEM). The means were 93.6 1.6% for EC). Cold-induced injury was significantly
higher in the EC solution than in the UW solution. In allobtained from a minimum of three separate experiments
with N  4 to 6 each. Data were analyzed by the Mann- subsequent experiments, cell injury was assessed after 20
hours of cold storage in either preservation solution.Whitney U test or one-way analysis of variance (ANOVA)
followed by the Dunnett post-test for multiple compari-
Effects of bioflavonoid preincubation onsons. Significance was set at a level of P  0.05.
cold storage-induced injury
Studies of structural and metabolic integrity. Prior to
RESULTS
20-hour cold storage in the UW or EC solution, cells were
Time course of cold-storage induced injury pre-incubated for three hours with various flavonoids at
a concentration of 100 mol/L (Table 1). Because ofStructural and functional cell injury induced by storage
of LLC-PK1 cells for up to 20 hours in either UW or EC earlier studies indicating the cytotoxicity of fisetin at 100
mol/L, a concentration of 50 mol/L was chosen forsolution followed by 60 minutes of rewarming was studied.
Both membrane integrity and metabolic activity, as de- this bioflavonoid. Pretreatment with either quercetin,
kaempferol, luteolin or fisetin significantly reduced celltermined by the LDH release and MTT test, were found
to decrease over time (Fig. 1). Cell injury progressively injury, whereas other flavonoids were either not or less
protective (Fig. 2). Quercetin, kaempferol, luteolin andincreased between 2.5 and 10 hours, a 20-hour cold stor-
age resulted in almost complete loss of cell viability (MTT, fisetin yielded almost complete preservation of structural
integrity in both the UW and EC solutions (LDH-release11.5  6.9% for UW and 2.5  1.1% for EC) and struc-
tural integrity (LDH-release, 67.2  6.9% for UW and for quercetin, 5.4  2.7% for UW and 8.4  4.2% for
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EC). Metabolic activity was maintained at almost 100% aged control cells (Table 2). Instead, there was a general
tendency for increased l-threonine transport activity inin the UW solution, compared to 60 to 80% in the EC
solution (MTT test for quercetin, 90.5  11.1% for UW flavonoid-pretreated LLC-PK1 cells. Amino acid trans-
port activity was not directly stimulated by flavonoids,and 80.0  12.8% for EC).
Studies of lipid peroxidation. Lipid peroxidation dur- as could be demonstrated in quercetin treated, non-cold
injured control cells.ing rewarming was assessed by malondialdehyde (MDA)
production. There was some background MDA produc- Concentration kinetics of luteolin and quercetin. Ef-
fects of quercetin and luteolin on cold-induced injurytion in confluent control cells at 37C (Table 1). Cold
storage strongly increased MDA production in the UW were examined covering a concentration range of 6.25
to 400 mol/L. The results for luteolin are presented in(2.7 1.2 nmol/mg protein) as well as in the EC solutions
(4.4  2.3 nmol/mg protein). Storage in EC solution led Figure 3, which shows a significant reduction of cell injury
for concentrations 	12.5 mol/L. Complete inhibitionto higher MDA formation than storage in UW solution,
matching the results of the LDH release and MTT test. of the LDH release was obtained with 25mol/L luteolin
in both preservation solutions (Fig. 3A). At this concen-Pretreatment with either quercetin, luteolin or kaemp-
ferol significantly reduced lipid peroxidation in both pres- tration metabolic activity was sustained almost completely
in the UW solution (91.4  11.9%), but only partiallyervation solutions, and pre-incubation with 50 mol/L
fisetin provided less protection (Table 1). In contrast, in the EC solution (64.1 5.2%; Fig. 3B). Full protection
of metabolic activity in EC solution was achieved atpretreatment with myricetin, morin, apigenin, naringe-
nin, catechin, silibinin and rutin resulted in significantly 300 mol/L luteolin. Similar results were observed by
pretreatment with quercetin (data not shown). Over theless inhibition of lipid peroxidation.
Structure-activity relationship. The selection of 11 concentration range studied, there was no indication of
bioflavonoid cytotoxicity.structurally related flavonoids allowed an analysis of the
relationships between structural characteristics and pro- Influence of rewarming time on the cold-protective ef-
tective activity (Table 1). Flavonoids in this study dif- fect of bioflavonoids. After demonstrating protective ef-
fered in number and arrangement of the hydroxyl substi- fects of bioflavonoids after short rewarming periods (60
tutes, in molecular size, degree of electron-delocalization min), it seemed important to observe if these cytopro-
of the ACB-ring system, structural planarity, and in lipo- tective effects could be sustained during extended re-
philicity. Flavonoids found to be protective in our experi- warming periods. Therefore, after a 20-hour cold storage,
ments (quercetin, kaempferol, luteolin and fisetin) preservation solutions were replaced by regular culture
shared characteristic structural features that differenti- medium supplemented with 4 mmol/L l-glutamine and
ated them from non-protective flavonoids: (1) two or cells were stored at 37C in 95% air/5% CO2 atmosphere
three hydroxyl-groups in position B3
, B4
 and C3; (2) for one, four or eight hours (Fig. 4; data for the UW
2,3-double bond in conjugation with 4-oxo function; and solution is not shown). Medium replacement served to
(3) no hydroxyl-groups in position B5
 and B6
. imitate clinical practice, where preservation solutions are
Note that quercetin in a glycosylated form (rutin  not suited for extended storage at 37C. Even up to
quercetin-rhamnoglycosid) was not protective. eight hours after medium replacement, significant cell
Studies of amino acid transport activity. Preincubation protection was observed after pretreatment with querce-
with quercetin, kaempferol, luteolin and fisetin provided tin, luteolin and kaempferol, whereas cells pretreated
prevention of structural and metabolic cell damage. with fisetin rapidly lost structural and functional integ-
However, biological cell functions were not sufficiently rity: EC solution, LDH-release for fisetin, 48.4  13.1%
assessed by the LDH release and MTT test. The proximal at 1 h, 78.1  4.4% at 4 h, and 88.9  2.8% at 8 h; MTT-
tubule is the main localization of renal amino acid re- test for fisetin, 54.8  6.0% at 1 h, 14.8  3.0% at 4 h,
absorption. Therefore, activity of amino acid transport 8.7  2.4% at 8 h (N  12).
systems represents a sensitive parameter for assessment
of functional cell integrity. In the proximal tubule apical
DISCUSSIONsodium-dependent transport of l-threonine is mediated
In view of the high incidence of delayed graft functionby the amino acid transport systems A and ASC, whereas
after kidney transplantation and the role of delayed graftsodium-independent transport occurs via the transport
function for the development of chronic allograft rejec-system L [24, 25]. The activities of these transport sys-
tion [3, 4], new strategies to protect renal proximal tu-tems were studied in LLC-PK1 cells effectively protected
bules from reactive oxygen species (ROS)-mediatedfrom cold-induced injury by flavonoid pretreatment and
ischemia-reperfusion injury need to be explored. Natu-compared to undamaged control cells.
rally occurring antioxidants might be useful in reducingCold-exposed cells that were pre-incubated with quer-
oxidative injury during kidney transplantation. We havecetin, kaempferol, luteolin and fisetin did not show any
reduction of l-threonine-uptake compared to undam- studied the cytoprotective effects of various bioflavo-
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Table 1. Structure of bioflavonoids under study and effects on cold-induced lipid peroxidation
TBARS nmol/mg protein
Substance Structure Control UW EC
(Continued)
noids on cell damage occurrence during cold storage and membrane lipid degradation, adenosine 5
-triphosphate
(ATP) depletion and DNA damage. During reperfusionrewarming in an in vitro model of renal proximal tubular
cells. Our results show that cellular tolerance toward molecular oxygen is reintroduced into the tissue, where
it reacts with hypoxanthine and xanthine oxidase to pro-cold-induced injury is dramatically increased by pretreat-
ment with bioflavonoids. It is demonstrated that cytopro- duce a burst of superoxide anion and hydrogen peroxide.
Superoxide anion and hydrogen peroxide react to formtective activity is not a property of bioflavonoids per se,
but rather depends on structural features, which were the highly reactive and cytotoxic hydroxyl radical, which
initiates lipid peroxidation of cell membranes [8]. How-further characterized in our studies. Our results point
toward inhibition of lipid peroxidation as an important ever, reperfusion does not appear to be a “conditio sine
qua non” for ROS-mediated injury, since there is grow-component of cytoprotection.
Production and release of ROS are key events during ing evidence for the occurrence of ROS-mediated cell
injury and iron-dependent membrane lipid peroxidationreperfusion injury, as demonstrated in cultured human
tubular cells, in the isolated perfused kidney model, and during cold-preservation alone [7, 8, 26].
In our study cell damage was assessed after 20 hours ofin animal models of renal transplantation [5, 6, 8]. The
marked increase in free radical generation is likely of cold ischemia followed by 60 minutes of warm ischemia
without prior change of preservation solution. There wasmitochondrial origin and is associated with substantial
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Table 1. (Continued)
TBARS nmol/mg protein
Substance Structure Control UW EC
Cells were pretreated with 100 mol/L of various flavonoids (50 mol/L for fisetin) and cold stored for 20 hours in UW or EC solution. TBARS
generation during 4 hours of rewarming in medium A was compared to undamaged control cells. Flavonoids were absent during cold storage and
rewarming. Each result represents the meanSD of at least N  12. ‘Rut’ is used as abbreviation for rutinose.
aP  0.01 vs. undamaged control cells
a high degree of cell injury observed after cell storage in dative effects of these additives seem to be limited by
auto-oxidation of glutathione and contamination of theeither of the two preservation solutions studied. Cellular
damage was higher in EC than in UW solution, confirm- preservation solution with traces of iron [30]. A loss of
antioxidative activity may explain our findings that func-ing several other reports from clinical and experimental
studies suggesting superiority of UW solution for kidney tional and structural cell integrity were dramatically re-
duced after storage in UW solution for 20 hours at 4C.preservation [26–28]. The major disadvantage of EC so-
lution lies in the presence of glucose, which causes cell The importance of free radical formation for cold-induced
cell injury has been suggested recently, when it wasswelling due to intracellular enzymatic breakdown. UW
solution is characterized by improved osmotic properties shown that adding to UW solution a lazaroid compound,
2-methyl-aminochroman, or an iron chelator, desferriox-due to substitution of glucose by metabolically inert, cell
impermeable substrates (lactobionic acid and raffinose) amine, enhanced cell survival after cold storage [8].
Bioflavonoids are a group of naturally-occurring phe-and hydroxyethyl starch, a colloid carrier [29]. Accord-
ingly, hypothermia-induced cell swelling and interstitial nolic compounds with known antioxidative properties
[14–17]. Bioflavonoids are found in various food prod-edema should be reduced. The UW solution also is sup-
plemented with allopurinol, a xanthine oxidase inhibitor, ucts including fruits, vegetables, tea and wine, and they
recently gained interest for their potential cardioprotec-and glutathione in order to minimize oxidative damage
during cold storage/reperfusion. However, the antioxi- tive activity related to the ‘French paradox’ [18, 19].
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Fig. 2. Protection from cold-induced injury by various flavonoids using the UW ( ) or EC () solution. Cells were pretreated for 3 hours with
100 mol/L of various flavonoids (except fisetin with 50 mol/L) in regular medium 199. Cell damage was assessed by the LDH release (A, B)
and MTT-test (C, D) after 20 hours of cold exposure in the UW (A, C) or EC solution (B, D) and 60 minutes of rewarming at 37C. Flavonoids
were absent during cold storage and rewarming. Each bar represents mean  SD of N 	 18. *P  0.01 vs. no flavonoid-pretreatment.
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Table 2. Amino acid transport activity in flavonoid-pretreated, cold-injured LLC-PK1 cells compared to undamaged control cells
l-Threonine No cold injury Cold injury
transport activity
pmol/mg protein/min No flavonoid Quercetin Quercetin Kaempferol Luteolin Fisetin
Sodium-independent transport
M199 34.93.9 31.62.8
UW 53.94.0a 58.04.8a 60.24.3a 57.73.9a
EC 31.01.8 34.82.7 36.62.3 42.32.7
Sodium-dependent transport
M199 197.238.2 201.525.9
UW 888.2159.0 761.9146.1 935.1190.5 881.4156.3
EC 696.4176.0 651.7223.7 774.5221.2 790.1193.1
Na-dependent and Na-independent l-threonine transport activities (pmol/mg protein/min) were measured in flavonoid-pretreated cells after 20 hours of cold
storage in UW or EC solution followed by 60 minutes of rewarming at 37C. Flavonoids were absent during cold storage and rewarming. Each condition represents
meanSEM of N  6 to 12.
aP  0.01 vs. undamaged control cells cultured in regular medium 199 (M199)
antioxidative and iron chelating properties, but more de-
tailed analyses of the mechanisms of protection are lack-
ing. Our study goes one step beyond these data in that, to
our knowledge, it is the first to examine the mechanisms
underlying the cytoprotective effects of bioflavonoids in
a model of cold storage/reperfusion-induced renal proxi-
mal tubular cell injury.
Confirming previous studies, our data demonstrate
that pretreatment with quercetin increases cellular toler-
ance toward cold storage and rewarming. To further
analyze the underlying mechanism of protection, struc-
ture-activity studies were performed with bioflavonoids
selected on base of their structural similarity to quercetin
(Table 1). These studies allowed us to delineate four
characteristic structural features required for maximum
protective potential:
1. Two or three hydroxyl-groups in position B3
, B4

and C3;
2. No hydroxyl-groups in position B5
 and B6
;
3. C2-C3 double bond in conjugation with 4-oxo func-
tion;
4. Hydroxyl group in A5 position.
All of these structural requirements are fulfilled by
quercetin, luteolin and kaempferol, those three biofla-Fig. 3. Protection from cold-induced injury by luteolin: Concentration
kinetics. Cells were preincubated with luteolin at concentrations rang- vonoids providing maximum protection in our studies.
ing from 6.25 to 400 mol/L followed by 20 hours of cold storage in Either no or significantly reduced protection was foundthe UW (A ) or EC solution (B ) and 60 minutes of rewarming in the
for bioflavonoids lacking the C-ring double bond or theabsence of luteolin. Cell damage was evaluated by LDH release (,
; left ordinate) and MTT-assay (,; right ordinate). Each condition 4-carboxy group (naringenin, catechin), and in cases where
represents mean  SEM of at least N  12. *P  0.01 for lowest BC-ring hydroxyl substitutes were either reduced (api-luteolin concentration vs. no flavonoid pretreatment.
genin) or increased (myricetin) in number, or altered in
their arrangement (morin). In these cases electron delo-
calization across the ACB-ring system is impaired [20].
Due to their lipophilicity, most of the bioflavonoids inAmong the more than 4000 flavonoid compounds known,
our study show a strong affinity to biological membranes.only quercetin, curcumin and silibinin have been applied
Interaction with biological membranes is drastically re-to models of renal transplantation [9, 26, 31]. The cyto-
protective effects of bioflavonoids added to the preserva- duced for non-lipophilic bioflavonoids, as it has been
demonstrated for rutin, a non-lipophilic quercetin gluco-tion solution were generally related to their acclaimed
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were rapidly lost during rewarming. This finding suggests
an important role of the 5-OH group for stability of the
formed flavonoid radical.
Cytoprotective effects of some flavonoids also have
been related to iron chelating properties in earlier studies
[9, 26, 31]. Our studies do not support this notion, be-
cause all flavonoids under study are excellent transition
metal ion chelators and the differences in protective bio-
activity cannot be explained by variations in chelating
activity. This is in accordance with the studies by van
Acker et al [34], who concluded that iron chelation does
not play a role in the antioxidant activity of the majority
of flavonoids. It may be concluded from our data also
that iron chelation appears to be of minor importance
for cytoprotection in cold-induced renal cell injury.
The observed structure-activity relationships among
various bioflavonoids lead us to propose following hy-
pothesis on the mechanism of protection: Lipophilic and
sterically near planar bioflavonoids are incorporated into
the membrane lipid bilayer and form stable low-energy
aroxyl radicals by the acceptance and delocalization of
free electrons. Oxidant-induced lipid peroxidation chain
reactions, which are perpetuated by free electrons, thus
will be interrupted. In further experiments we confirmed
the occurrence of lipid peroxidation in this model, as
has been shown by others [7, 26], and demonstrated that
quercetin, kaempferol and luteolin almost completely
inhibit TBARS generation. These findings are in accor-
dance with previous reports by our group and others on
the inhibition of oxidant-induced lipid peroxidation byFig. 4. Effects of extended rewarming periods on cold-injured, flavo-
noid-pretreated LLC-PK1 cells. Cells were pretreated for 3 hours with quercetin [14, 16, 20, 35–38]. We have previously shown
no flavonoid ( ), quercetin (100 mol/L; ), kaempferol (100 that cytoprotection by bioflavonoids is at least partially
mol/L; ), luteolin (100 mol/L; ) or fisetin (50 mol/L; )
dependent on initiation of lipid peroxidation [16]. Similarfollowed by cold preservation in the EC solution. After 20 hours of
cold storage preservation solution was replaced by regular medium structure-activity relations observed in our current and
199 and cells were rewarmed for 1, 4, or 8 hours at 37C. Cell damage previous studies indicate that the same cell damage
was assessed by LDH release (A ) and MTT-assay (B ). Flavonoids were
mechanisms may be active during cold storage-inducedabsent during cold storage and rewarming. Each condition represents
mean  SD of at least N  12. *P  0.01 vs. cell damage observed and oxidant-induced injury.
after one hour of rewarming for the identical flavonoid-pretreatment. In our current study, apical amino acid transport activ-
ity was used as a functional correlate of cell membrane
integrity. Various amino acid transport proteins are ex-
pressed in renal proximal tubules and LLC-PK1 cells andside [32]. Our finding that rutin lacked protective proper-
ties stresses the importance of lipophilicity-related mem- are defined by substrate specificity [25]. We have studied
uptake of the neutral amino acid l-threonine, a substratebrane affinity for the protective potential of quercetin.
Another important structural characteristic of quercetin of sodium-dependent transport systems A and ASC and
sodium-independent system L [24]. Completely sus-is its steric geometry. Due to its almost complete three-
dimensional planarity this flavonoid can easily interact tained transport activity for l-threonine was found in
quercetin, luteolin and kaempferol pretreated LLC-PK1with the ordered structure of lipid bilayers [33]. Planarity
is disturbed by introduction of a hydroxyl group in either cells after 20 hours of cold storage in the UW or EC
solution. Since Na-dependent amino acid transport is5
 (myricetin) or 6
 position of the B-ring (morin) or a
large angular substitute in the B-ring position (silibinin), energy dependent, our data suggest that tubular cells
protected from cold-induced injury by pretreatment withall variations resulting in a complete loss of cytoprotec-
tion. Fisetin lacks the 5-OH group of the A-ring, but selected bioflavonoids may not be energy depleted. ATP-
depletion occurs early during ischemic renal tubularfulfills the other structural requirements. Cytoprotective
properties were found for fisetin, however, in contrast damage and contributes to sustained acute renal failure.
During ischemic injury proximal tubule Na,K-ATPaseto quercetin, kaempferol and luteolin, protective effects
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oxidant-induced lipid-peroxidation in cultured renal tubular epithe-expression is dysregulated and ATP depletion has been
lial cells (LLC-PK1) by quercetin. Free Radical Res 29:451–460, 1998reported in cold storage-injured human renal tubular 17. Kuhlmann MK, Horsch E, Burkhardt G, et al: Reduction of
cisplatin toxicity in cultured renal tubular cells by the bioflavonoidcells [8, 39, 40]. Whether these alterations are prevented
quercetin. Arch Toxicol 72:536–540, 1998by bioflavonoids needs to be examined further.
18. Hertog MGL, Kromhout D, Aravanis C, et al: Flavonoid intake
Our study shows that survival of renal proximal tubu- and long term risk of coronary heart disease and cancer in the
Seven Countries Study. Arch Intern Med 155:381–386, 1995lar cells during cold preservation in the EC or UW solu-
19. Hertog MGL, Feskens EJM, Hollman PCH, et al: Dietary antioxi-tion is drastically improved by pretreatment with biofla-
dant flavonoids and risk of coronary heart disease: The Zutphen
vonoids. Whether these findings can be transferred to Elderly Study. Lancet 342:1007–1011, 1993
20. Bors W, Heller W, Michel C, Saran M: Flavonoids as antioxi-whole organ preservation remains to be demonstrated.
dants: Determination of radical scavenging activities. Methods En-Based upon our data, selection of bioflavonoids for fur-
zymol 186:343–355, 1990
ther studies in renal transplantation and kidney preserva- 21. Mosmann T: Rapid colorimetric assay for cellular growth and
survival: Application to proliferation and cytotoxic assays. J Immu-tion will be facilitated.
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